top of page

$5.7 Million EBITDA Clinical Laboratory Reagent, Equipment, and Software Distributor in Panama and Guatemala

Listing Code:

XYDME2C

State:

Not Disclosed

Category:

DME & HME

Asking Price:

$18,000,000

Revenue:

$12,000,000

XYDME2C
Company Overview

PRIME exits and American Healthcare Capital is pleased to introduce a Clinical Laboratory Reagent, Equipment, and Software Distributor company for sale. The opportunity consists of 3 independently operated and managed companies that distribute high quality reagents, advanced technology instrumentation, and software systems to clinical laboratories and blood banks in Guatemala and Panama.

The business model that drives revenue for the 3 companies is to provide testing instruments, software, and training to customers. The majority of company’s revenues are derived from distribution of the proprietary reagents needed to perform each test.

The companies have an estimated 60-90% market share in the immunohematology/blood typing business and a 45-60% market share in quality control usage in their respective countries. Their customer base totals over 90 accounts ranging from privately held clinical laboratories to major government (Ministry of Health and Social Security) blood banks and hospitals.


Financial Overview

The company has been growing steadily as has EBITDA over the last years.  Revenue and EBITDA for 2024 is projected to remain steady.


Staff overview

The 3 entities operate with 51 employees. The operations are locally managed and organized into the following functions: Sales and Technical Support, Application Specialists, Engineering and Information Technology, Customer Service, and Administration. All staff are expected to stay on.


Asking Price

The asking price for this opportunity is $18 million.

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.

YOU ONLY NEED TO COMPLETE A BUYER PROFILE ONCE. 

2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:

XYDME2C

Listing Title:

$5.7 Million EBITDA Clinical Laboratory Reagent, Equipment, and Software Distributor in Panama and Guatemala

Heading 4

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

Join our mailing list to receive our latest news, and listings.

Thanks for submitting!

About us
 

PRIME exits is a registration pending trademark for Nazeri & Company LLCan independent affiliate of American Healthcare Capital. Nazeri & Company, Co. Ltd. is an international subsidiary of Nazeri & Company LLC. We are a merger and acquisition advisory firm focused on the healthcare industry with a network of 50+ M&A analysts and advisors. 

 

Locations

Los Angeles

Las Vegas

Bangkok

Vancouver, BC

Milan, Italy

Contact us

 

1-800- 424-3388 HEAD OFFICE

1-310-625-7889 Jack Eskenazi

1-702-506-3392 Dr. Allen Nazeri 

Valuation Team

Jack@ahcteam.com

Allen@ahcteam.com

Allen@pexits.com

Prime exits Bar code
Association Corporate Growth Logo
PRIME exits member masource-logo
CM&AP PRIME exits
bottom of page